AbbVie Inc. Short-term Debt, Fair Value
AbbVie Inc. (ABBV) had Short-term Debt, Fair Value of $494.00 million as of 2016-06-30, per its 10-Q filed 2016-08-05.
Discontinued › Notes › Debt
us-gaap:ShorttermDebtFairValue · last filed 2016-08-05
- 2016-06-30: Short-term Debt, Fair Value $494.00M.
- 2016-03-31: Short-term Debt, Fair Value $400.00M.
- 2015-12-31: Short-term Debt, Fair Value $406.00M.
- 2015-09-30: Short-term Debt, Fair Value $760.00M.
| Period end | Short-term Debt, Fair Value |
|---|---|
| 2016-06-30 | $494.00M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $400.00M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $406.00M 10-Q · filed 2016-08-05 |
| 2015-09-30 | $760.00M 10-Q · filed 2015-11-06 |
| 2014-12-31 | $425.00M 10-K · filed 2016-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |